Anti-inflammatory effects of cell-based therapy with tyrosine hydroxylase-positive catecholaminergic cells in experimental arthritis

Annals of the Rheumatic Diseases

Volumn 74, Issue 2, 2015, Pages 444-451

  Jenei Lanzl, Zsuzsa ^a   Capellino, Silvia ^a,b   Kees, Frieder ^c   Fleck, Martin ^a   Lowin, Torsten ^a   Straub, Rainer H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; FERROUS ION; INTERLEUKIN 6; METIROSINE; OXIDOPAMINE; TUMOR NECROSIS FACTOR; TYROSINE 3 MONOOXYGENASE; CATECHOLAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CATECHOLAMINE RELEASE; CATECHOLAMINE SYNTHESIS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL THERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; EXPERIMENTAL ARTHRITIS; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL; SYNOVIOCYTE; ANIMAL; CELL TRANSPLANTATION; DBA MOUSE; IN VITRO STUDY; INFLAMMATION; METABOLISM; NEURAL STEM CELL; OSTEOARTHRITIS; PATHOLOGY; PROCEDURES; RHEUMATOID ARTHRITIS; SYNOVIUM; TRANSPLANTATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CATECHOLAMINES; CELL TRANSPLANTATION; HUMANS; IN VITRO TECHNIQUES; INFLAMMATION; MICE; MICE, INBRED DBA; NEURAL STEM CELLS; OSTEOARTHRITIS; SYNOVIAL MEMBRANE; TYROSINE 3-MONOOXYGENASE;

EID: 84921389774     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203925     Document Type: Article

References (35)

1. Bijlsma JW, Masi A, Straub RH, et al. Neuroendocrine immune system involvement in rheumatology. Ann N Y Acad Sci 2006;1069:xviii-xxxiv.
2. Elenkov IJ. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 2008;52:40-51.
3. Eskandari F, Webster JI, Sternberg EM. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther 2003;5:251-65.
4. Hench PS, Slowcumb CH, Polley HF, et al. Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases. J Am Med Assoc 1950;144:1327-35.
5. Levine JD, Clark R, Devor M, et al. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984;226:547-9.
6. Bellinger DL, Millar BA, Perez S, et al. Sympathetic modulation of immunity: relevance to disease. Cell Immunol 2008;252:27-56.
7. Ebbinghaus M, Gajda M, Boettger MK, et al. The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses. Ann Rheum Dis 2012;71:253-61.
8. Härle P, Mobius D, Carr DJ, et al. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum 2005;52:1305-13.
9. Capellino S, Cosentino M, Wolff C, et al. Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target. Ann Rheum Dis 2010;69:1853-60.
10. Capellino S, Weber K, Gelder M, et al. First appearance and location of catecholaminergic cells during experimental arthritis and elimination by chemical sympathectomy. Arthritis Rheum 2012;64:1110-18.
11. Miller LE, Justen HP, Schölmerich J, et al. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000;14:2097-107.
12. Miller LE, Grifka J, Schölmerich J, et al. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial in flammation in rheumatoid arthritis. J Rheumatol 2002;29:427-35.
13. Dunkley PR, Bobrovskaya L, Graham ME, et al. Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 2004;91:1025-43.
14. Haycock JW. Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J Biol Chem 1990;265:11682-91.
15. Haavik J, Martinez A, Flatmark T. pH-dependent release of catecholamines from tyrosine hydroxylase and the effect of phosphorylation of Ser-40. FEBS Lett 1990;262:363-5.
16. Schmidt TS, Alp NJ. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Lond) 2007;113:47-63.
17. Nakashima A. Proteasomal degradation of tyrosine hydroxylase and neurodegeneration. J Neurochem 2012;120:199-201.
18. Kumar GK, Kim DK, Lee MS, et al. Activation of tyrosine hydroxylase by intermittent hypoxia: involvement of serine phosphorylation. J Appl Physiol 2003;95:536-44.
19. Kumar GK. Hypoxia. 3. Hypoxia and neurotransmitter synthesis. Am J Physiol Cell Physiol 2011;300:C743-51.
20. Goryo K, Torii S, Yasumoto K, et al. Tumour necrosis factor-alpha suppresses the hypoxic response by NF-kappaB-dependent induction of inhibitory PAS domain protein in PC12 cells. J Biochem 2011;150:311-18.
21. Gaber T, Dziurla R, Tripmacher R, et al. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! Ann Rheum Dis 2005;64:971-80.
22. Muz B, Khan MN, Kiriakidis S, et al. Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis. Arthritis Res Ther 2009;11:201.
23. Ng CT, Biniecka M, Kennedy A, et al. Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis 2010;69:1389-95.
24. Trzaska KA, Rameshwar P. Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells. Methods Mol Biol 2011;698:295-303.
25. Zhu H, Guo ZK, Jiang XX, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 2010;5:550-60.
26. Zhang SC, Wernig M, Duncan ID, et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001;19:1129-33.
27. Ader R. Psychoneuroimmunology. San Diego, CA: Elsevier-Academic Press, 2007.
28. Pongratz G, Straub RH. Role of peripheral nerve fibres in acute and chronic inflammation in arthritis. Nat Rev Rheumatol 2012;10:117-26.
29. Flierl MA, Rittirsch D, Nadeau BA, et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 2007;449:721-5.
30. Gozal E, Shah ZA, Pequignot JM, et al. Tyrosine hydroxylase expression and activity in the rat brain: differential regulation after long-term intermittent or sustained hypoxia. J Appl Physiol 2005;99:642-9.
31. Kato K, Yamaguchi-Yamada M, Yamamoto Y. Short-term hypoxia increases tyrosine hydroxylase immunoreactivity in rat carotid body. J Histochem Cytochem 2010;58:839-46.
32. Ghezzi P, Dinarello CA, Bianchi M, et al. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 1991;3:189-94.
33. Konisti S, Kiriakidis S, Paleolog EM. Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 2012;8:153-62.
34. Tyndall A, Walker UA, Cope A, et al. Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 2007;9:301.
35. Härle P, Pongratz G, Albrecht J, et al. An early sympathetic nervous system influence exacerbates collagen-induced arthritis via CD4+CD25+ cells. Arthritis Rheum 2008;58:2347-55.